FoxP3+ regulatory T cells attenuate experimental necrotizing enterocolitis

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Dingle, Bridgette M ^a   Liu, Yuying ^a   Fatheree, Nicole Y ^a   Min, Juleen ^a   Rhoads, J Marc ^a   Tran, Dat Q ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD11B ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD86 ANTIGEN; GLYCOPROTEIN P 15095; INTERLEUKIN 2 RECEPTOR ALPHA; L SELECTIN; TRANSCRIPTION FACTOR FOXP3;

ADOPTIVE TRANSFER; ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL MATURATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; DOWN REGULATION; EXPERIMENTAL DISEASE; EXPERIMENTAL NECROTIZING ENTEROCOLITIS; FLOW CYTOMETRY; ILEUS; IMMUNOREGULATION; IN VIVO STUDY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; LYMPHOCYTE FUNCTION; MESENTERY LYMPH NODE; MOLECULAR DYNAMICS; NECROTIZING ENTEROCOLITIS; NEWBORN; NONHUMAN; ONTOGENY; OUTCOME ASSESSMENT; PATHOGENESIS; PROTEIN EXPRESSION; RAT; REGULATORY T LYMPHOCYTE; SURVIVAL RATE; TREATMENT RESPONSE; WEIGHT REDUCTION;

ANIMALS; ENTEROCOLITIS, NECROTIZING; FORKHEAD TRANSCRIPTION FACTORS; IMMUNOTHERAPY; RATS; RATS, SPRAGUE-DAWLEY; T-LYMPHOCYTES, REGULATORY;

EID: 84893386165     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0082963     Document Type: Article

References (53)

1. Henry MC, Moss RL (2009) Necrotizing enterocolitis. Annu Rev Med 60: 111- 124.
2. Lin PW, Nasr TR, Stoll BJ (2008) Necrotizing enterocolitis: recent scientific advances in pathophysiology and prevention. Semin Perinatol 32: 70-82. (Pubitemid 351381166)
3. Neu J, Walker WA (2011) Necrotizing enterocolitis. N Engl J Med 364: 255- 264.
4. Luig M, Lui K (2005) Epidemiology of necrotizing enterocolitis-Part II: Risks and susceptibility of premature infants during the surfactant era: a regional study. J Paediatr Child Health 41: 174-179. (Pubitemid 40646626)
5. Neu J, Mshvildadze M, Mai V (2008) A roadmap for understanding and preventing necrotizing enterocolitis. Curr Gastroenterol Rep 10: 450-457.
6. Henry MC, Lawrence MR (2005) Surgical therapy for necrotizing enterocolitis: bringing evidence to the bedside. Semin Pediatr Surg 14: 181-190. (Pubitemid 41111605)
7. Petrosyan M, Guner YS, Williams M, Grishin A, Ford HR (2009) Current concepts regarding the pathogenesis of necrotizing enterocolitis. Pediatr Surg Int 25: 309-318.
8. Sakaguchi S, Miyara M, Costantino CM, Hafler DA (2010) FOXP3+ regulatory T cells in the human immune system. Nat Rev Immunol 10: 490-500.
9. Tang Q, Bluestone JA (2008) The Foxp3+ regulatory T cell: a jack of all trades, master of regulation. Nat Immunol 9: 239-244. (Pubitemid 351267321)
10. Lahl K, Loddenkemper C, Drouin C, Freyer J, Arnason J, et al. (2007) Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease. J Exp Med 204: 57-63. (Pubitemid 46148756)
11. Nishizuka Y, Sakakura T (1969) Thymus and reproduction: sex-linked dysgenesia of the gonad after neonatal thymectomy in mice. Science 166: 753-755.
12. Atarashi K, Tanoue T, Shima T, Imaoka A, Kuwahara T, et al. (2011) Induction of colonic regulatory T cells by indigenous Clostridium species. Science 331: 337-341.
13. Fontenot JD, Dooley JL, Farr AG, Rudensky AY (2005) Developmental regulation of Foxp3 expression during ontogeny. J Exp Med 202: 901-906. (Pubitemid 41396890)
14. Moraes-Vasconcelos D, Costa-Carvalho BT, Torgerson TR, Ochs HD (2008) Primary immune deficiency disorders presenting as autoimmune diseases: IPEX and APECED. J Clin Immunol 28 Suppl 1: S11-S19.
15. Barnes MJ, Powrie F (2009) Regulatory T cells reinforce intestinal homeostasis. Immunity 31: 401-411.
16. Collins CB, Aherne CM, McNamee EN, Lebsack MD, Eltzschig H, et al. (2012) Flt3 ligand expands CD103(+) dendritic cells and FoxP3(+) T regulatory cells, and attenuates Crohn's-like murine ileitis. Gut 61: 1154-1162.
17. Maloy KJ, Powrie F (2011) Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature 474: 298-306.
18. Boden EK, Snapper SB (2008) Regulatory T cells in inflammatory bowel disease. Curr Opin Gastroenterol 24: 733-741.
19. Hardenberg G, Steiner TS, Levings MK (2011) Environmental influences on T regulatory cells in inflammatory bowel disease. Semin Immunol 23: 130-138.
20. Maul J, Loddenkemper C, Mundt P, Berg E, Giese T, et al. (2005) Peripheral and intestinal regulatory CD4+ CD25(high) T cells in inflammatory bowel disease. Gastroenterology 128: 1868-1878. (Pubitemid 40824698)
21. Veltkamp C, Anstaett M, Wahl K, Moller S, Gangl S, et al. (2011) Apoptosis of regulatory T lymphocytes is increased in chronic inflammatory bowel disease and reversed by anti-TNFalpha treatment. Gut 60: 1345-1353.
22. Weitkamp JH, Rudzinski E, Koyama T, Correa H, Matta P, et al. (2009) Ontogeny of FOXP3(+) regulatory T cells in the postnatal human small intestinal and large intestinal lamina propria. Pediatr Dev Pathol 12: 443-449.
23. Weitkamp JH, Koyama T, Rock MT, Correa H, Goettel JA, et al. (2013) Necrotising enterocolitis is characterised by disrupted immune regulation and diminished mucosal regulatory (FOXP3)/effector (CD4, CD8) T cell ratios. Gut 62: 73-82.
24. Liu Y, Fatheree NY, Mangalat N, Rhoads JM (2012) Lactobacillus reuteri strains reduce incidence and severity of experimental necrotizing enterocolitis via modulation of TLR4 and NF-kappaB signaling in the intestine. Am J Physiol Gastrointest Liver Physiol 302: G608-G617.
25. Liu Y, Fatheree NY, Dingle BM, Tran DQ, Rhoads M (2013) Lactobacillus reuteri DSM 17938 changes the frequency of Foxp3+ regulatory T cells in the intestine and mesenteric lymph node in experimental necrotizing enterocolitis. PLoS ONE 8 (2): e56547.
26. Nadler EP, Dickinson E, Knisely A, Zhang XR, Boyle P, et al. (2000) Expression of inducible nitric oxide synthase and interleukin-12 in experimental necrotizing enterocolitis. J Surg Res 92: 71-77. (Pubitemid 30437462)
27. Liu Y, Zhu L, Fatheree NY, Liu X, Pacheco SE, et al. (2009) Changes in intestinal Toll-like receptors and cytokines precede histological injury in a rat model of necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol 297: G442-G450.
28. Dvorak B, Khailova L, Clark JA, Hosseini DM, Arganbright KM, et al. (2008) Comparison of epidermal growth factor and heparin-binding epidermal growth factor-like growth factor for prevention of experimental necrotizing enterocolitis. J Pediatr Gastroenterol Nutr 47: 11-18.
29. Shneider BL, Dawson PA, Christie DM, Hardikar W, Wong MH, et al. (1995) Cloning and molecular characterization of the ontogeny of a rat ileal sodiumdependent bile acid transporter. J Clin Invest 95: 745-754.
30. Liedel JL, Guo Y, Yu Y, Shiou SR, Chen S, et al. (2011) Mother's milk-induced Hsp70 expression preserves intestinal epithelial barrier function in an immature rat pup model. Pediatr Res 69: 395-400.
31. Ran-Ressler RR, Khailova L, Arganbright KM, Adkins-Rieck CK, Jouni ZE, et al. (2011) Branched chain fatty acids reduce the incidence of necrotizing enterocolitis and alter gastrointestinal microbial ecology in a neonatal rat model. PLoS ONE 6: e29032.
32. Tayman C, Uckan D, Kilic E, Ulus AT, Tonbul A, et al. (2011) Mesenchymal stem cell therapy in necrotizing enterocolitis: a rat study. Pediatr Res 70: 489- 494.
33. Sakaguchi S, Sakaguchi N, Shimizu J, Yamazaki S, Sakihama T, et al. (2001) Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol Rev 182: 18-32. (Pubitemid 33070205)
34. McClymont SA, Putnam AL, Lee MR, Esensten JH, Liu W, et al. (2011) Plasticity of human regulatory T cells in healthy subjects and patients with type 1 diabetes. J Immunol 186: 3918-3926.
35. Thornton AM, Korty PE, Tran DQ, Wohlfert EA, Murray PE, et al. (2010) Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3 + T regulatory cells. J Immunol 184: 3433-3441.
36. Sun CM, Hall JA, Blank RB, Bouladoux N, Oukka M, et al. (2007) Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J Exp Med 204: 1775-1785. (Pubitemid 47236316)
37. DiPaolo RJ, Brinster C, Davidson TS, Andersson J, Glass D, et al. (2007) Autoantigen-specific TGFbeta-induced Foxp3+ regulatory T cells prevent autoimmunity by inhibiting dendritic cells from activating autoreactive T cells. J Immunol 179: 4685-4693.
38. Tran DQ, Glass DD, Uzel G, Darnell DA, Spalding C, et al. (2009) Analysis of adhesion molecules, target cells, and role of IL-2 in human FOXP3+ regulatory T cell suppressor function. J Immunol 182: 2929-2938.
39. Tran DQ, Shevach EM (2009) Therapeutic potential of FOXP3(+) regulatory T cells and their interactions with dendritic cells. Hum Immunol 70: 294-299.
40. Wing K, Onishi Y, Prieto-Martin P, Yamaguchi T, Miyara M, et al. (2008) CTLA-4 control over Foxp3+ regulatory T cell function. Science 322: 271-275.
41. Miyara M, Gorochov G, Ehrenstein M, Musset L, Sakaguchi S, et al. (2011) Human FoxP3 + regulatory T cells in systemic autoimmune diseases. Autoimmun Rev 10: 744-755.
42. Muller YD, Golshayan D, Ehirchiou D, Wekerle T, Seebach JD, et al. (2009) T regulatory cells in xenotransplantation. Xenotransplantation 16: 121-128.
43. Sakaguchi S (2011) Regulatory T cells: history and perspective. Methods Mol Biol 707: 3-17.
44. Riley JL, June CH, Blazar BR (2009) Human T regulatory cell therapy: take a billion or so and call me in the morning. Immunity 30: 656-665.
45. Tang Q, Bluestone JA, Kang SM (2012) CD4(+)Foxp3(+) regulatory T cell therapy in transplantation. J Mol Cell Biol 4: 11-21.
46. Sodhi C, Richardson W, Gribar S, Hackam DJ (2008) The development of animal models for the study of necrotizing enterocolitis. Dis Model Mech 1: 94- 98.
47. Michaelsson J, Mold JE, McCune JM, Nixon DF (2006) Regulation of T cell responses in the developing human fetus. J Immunol 176: 5741-5748.
48. Mold JE, Michaelsson J, Burt TD, Muench MO, Beckerman KP, et al. (2008) Maternal alloantigens promote the development of tolerogenic fetal regulatory T cells in utero. Science 322: 1562-1565.
49. Davidson TS, Shevach EM (2011) Polyclonal Treg cells modulate T effector cell trafficking. Eur J Immunol 41: 2862-2870.
50. Zheng Y, Manzotti CN, Liu M, Burke F, Mead KI, et al. (2004) CD86 and CD80 differentially modulate the suppressive function of human regulatory T cells. J Immunol 172: 2778-2784. (Pubitemid 38263661)
51. Collins AV, Brodie DW, Gilbert RJ, Iaboni A, Manso-Sancho R, et al. (2002) The interaction properties of costimulatory molecules revisited. Immunity 17: 201-210. (Pubitemid 35245962)
52. Nolan A, Kobayashi H, Naveed B, Kelly A, Hoshino Y, et al. (2009) Differential role for CD80 and CD86 in the regulation of the innate immune response in murine polymicrobial sepsis. PLoS ONE 4: e6600.
53. Lan Q, Zhou X, Fan H, Chen M, Wang J, et al. (2012) Polyclonal CD4+Foxp3+ Treg cells induce TGFbeta-dependent tolerogenic dendritic cells that suppress the murine lupus-like syndrome. J Mol Cell Biol 4: 409-419.